|
Case
|
Pathological diagnosis
|
CD5
|
CD10
|
CD20
|
CD79a
|
BCL2
|
BCL6
|
EBER
|
MUM1
|
Ki-67 index
|
Phenotype
|
|---|
|
1
|
DLBCL, NOS
|
−
|
−
|
+
|
+
|
+
|
−
|
+
|
−
|
70-80%
|
Non-GCB
|
|
2
|
DLBCL, NOS
|
−
|
−
|
+
|
+
|
−
|
+
|
−
|
−
|
90%
|
GCB
|
|
3
|
DLBCL, NOS
|
+
|
−
|
+
|
+
|
+
|
−
|
−
|
+
|
80%
|
Non-GCB
|
|
4
|
DLBCL, NOS
|
−
|
−
|
+
|
ND
|
+
|
+
|
−
|
+
|
75-90%
|
Non-GCB
|
|
5
|
DLBCL, NOS
|
+
|
−
|
+
|
+
|
+
|
+
|
−
|
+
|
90-99%
|
Non-GCB
|
|
6
|
DLBCL, NOS
|
−
|
−
|
+
|
+
|
+
|
+
|
−
|
+
|
75-90%
|
Non-GCB
|
|
7
|
DLBCL, NOS
|
−
|
−
|
+
|
+
|
−
|
−
|
−
|
+
|
90-99%
|
Non-GCB
|
-
DLBCL diffuse large B-cell lymphoma, GCB germinal center B-cell phenotype, ND not done, NOS not otherwise specified.
